{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T09:59:25Z","timestamp":1696586365779},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T00:00:00Z","timestamp":1354924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00428-012-1342-8","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T04:08:01Z","timestamp":1354853281000},"page":"211-217","source":"Crossref","is-referenced-by-count":4,"title":["Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas"],"prefix":"10.1007","volume":"462","author":[{"given":"Maurits","family":"de Vries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge Briaire-de","family":"Bruijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Cleton-Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn J. A.","family":"Malessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andel G. L.","family":"van der Mey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pancras C. W.","family":"Hogendoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,8]]},"reference":[{"key":"1342_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/neuonc\/nop010","volume":"12","author":"VF Mautner","year":"2010","unstructured":"Mautner VF, Nguyen R, Kutta H et al (2010) Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 12:14\u201318","journal-title":"Neuro Oncol"},{"key":"1342_CR2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/322644a0","volume":"322","author":"BR Seizinger","year":"1986","unstructured":"Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644\u2013647","journal-title":"Nature"},{"key":"1342_CR3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515\u2013521","journal-title":"Nature"},{"key":"1342_CR4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791\u2013800","journal-title":"Cell"},{"key":"1342_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2148-5-69","volume":"5","author":"K Golovnina","year":"2005","unstructured":"Golovnina K, Blinov A, Akhmametyeva EM et al (2005) Evolution and origin of merlin, the product of the neurofibromatosis type 2 (NF2) tumor-suppressor gene. BMC Evol Biol 5:69","journal-title":"BMC Evol Biol"},{"key":"1342_CR6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1227\/NEU.0b013e3181ec7b71","volume":"67","author":"M Aarhus","year":"2010","unstructured":"Aarhus M, Bruland O, Saetran HA et al (2010) Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas. Neurosurgery 67:998\u20131019","journal-title":"Neurosurgery"},{"key":"1342_CR7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/3.2.347","volume":"3","author":"RM Irving","year":"1994","unstructured":"Irving RM, Moffat DA, Hardy DG et al (1994) Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 3:347\u2013350","journal-title":"Hum Mol Genet"},{"key":"1342_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2","volume":"17","author":"LB Jacoby","year":"1996","unstructured":"Jacoby LB, MacCollin M, Barone R et al (1996) Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer 17:45\u201355","journal-title":"Genes Chromosomes Cancer"},{"key":"1342_CR9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/hmg\/3.6.885","volume":"3","author":"J Sainz","year":"1994","unstructured":"Sainz J, Huynh DP, Figueroa K et al (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885\u2013891","journal-title":"Hum Mol Genet"},{"key":"1342_CR10","first-page":"1022","volume":"54","author":"RH Lekanne Deprez","year":"1994","unstructured":"Lekanne Deprez RH, Bianchi AB, Groen NA et al (1994) Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022\u20131029","journal-title":"Am J Hum Genet"},{"key":"1342_CR11","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1038\/onc.2010.363","volume":"29","author":"KD Hadfield","year":"2010","unstructured":"Hadfield KD, Smith MJ, Urquhart JE et al (2010) Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29:6216\u20136221","journal-title":"Oncogene"},{"key":"1342_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.49.1.267","volume":"49","author":"DH Gutmann","year":"1997","unstructured":"Gutmann DH, Giordano MJ, Fishback AS et al (1997) Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 49:267\u2013270","journal-title":"Neurology"},{"key":"1342_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s004010050608","volume":"93","author":"T Hitotsumatsu","year":"1997","unstructured":"Hitotsumatsu T, Iwaki T, Kitamoto T et al (1997) Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol 93:225\u2013232","journal-title":"Acta Neuropathol"},{"key":"1342_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00005072-199704000-00007","volume":"56","author":"DP Huynh","year":"1997","unstructured":"Huynh DP, Mautner V, Baser ME et al (1997) Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. J Neuropathol Exp Neurol 56:382\u2013390","journal-title":"J Neuropathol Exp Neurol"},{"key":"1342_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2443.2001.00432.x","volume":"6","author":"T Kino","year":"2001","unstructured":"Kino T, Takeshima H, Nakao M et al (2001) Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes Cells 6:441\u2013454","journal-title":"Genes Cells"},{"key":"1342_CR16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2990.2010.01090.x","volume":"36","author":"PJ Kullar","year":"2010","unstructured":"Kullar PJ, Pearson DM, Malley DS et al (2010) CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas. Neuropathol Appl Neurobiol 36:505\u2013514","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1342_CR17","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/JCO.2010.30.0830","volume":"28","author":"C Serrano","year":"2010","unstructured":"Serrano C, Simonetti S, Hernandez J et al (2010) BRAF V600E mutations in benign and malignant peripheral nerve sheath tumors. J Clin Oncol 28:15s (abstract)","journal-title":"J Clin Oncol"},{"key":"1342_CR18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405","journal-title":"Acta Neuropathol"},{"key":"1342_CR19","doi-asserted-by":"crossref","first-page":"418672","DOI":"10.1155\/2012\/418672","volume":"2012","author":"S Dahiya","year":"2012","unstructured":"Dahiya S, Yu J, Kaul A et al (2012) Novel BRAF alteration in a sporadic pilocytic astrocytoma. Case Report Med 2012:418672","journal-title":"Case Report Med"},{"key":"1342_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/NEN.0b013e31823f2cb0","volume":"71","author":"A Lin","year":"2012","unstructured":"Lin A, Rodriguez FJ, Karajannis MA et al (2012) BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol 71:66\u201372","journal-title":"J Neuropathol Exp Neurol"},{"key":"1342_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-004-0936-x","volume":"109","author":"D Basto","year":"2005","unstructured":"Basto D, Trovisco V, Lopes JM et al (2005) Mutation analysis of B-RAF gene in human gliomas. Acta Neuropathol 109:207\u2013210","journal-title":"Acta Neuropathol"},{"key":"1342_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00401-007-0239-0","volume":"114","author":"J Jeuken","year":"2007","unstructured":"Jeuken J, van den Broecke C, Gijsen S et al (2007) RAS\/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations. Acta Neuropathol 114:121\u2013133","journal-title":"Acta Neuropathol"},{"key":"1342_CR23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1215\/15228517-2009-003","volume":"11","author":"F Perrone","year":"2009","unstructured":"Perrone F, Da RL, Orsenigo M et al (2009) PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor. Neuro Oncol 11:725\u2013736","journal-title":"Neuro Oncol"},{"key":"1342_CR24","first-page":"1493","volume":"23","author":"JT Fraenzer","year":"2003","unstructured":"Fraenzer JT, Pan H, Minimo L Jr et al (2003) Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int J Oncol 23:1493\u20131500","journal-title":"Int J Oncol"},{"key":"1342_CR25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","volume":"67","author":"H Morrison","year":"2007","unstructured":"Morrison H, Sperka T, Manent J et al (2007) Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67:520\u2013527","journal-title":"Cancer Res"},{"key":"1342_CR26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-291X(03)00124-4","volume":"302","author":"JY Lim","year":"2003","unstructured":"Lim JY, Kim H, Kim YH et al (2003) Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway. Biochem Biophys Res Commun 302:238\u2013245","journal-title":"Biochem Biophys Res Commun"},{"key":"1342_CR27","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1073\/pnas.0510651103","volume":"103","author":"DN Chadee","year":"2006","unstructured":"Chadee DN, Xu D, Hung G et al (2006) Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf\/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci USA 103:4463\u20134468","journal-title":"Proc Natl Acad Sci USA"},{"key":"1342_CR28","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.febslet.2012.03.016","volume":"586","author":"L Zhou","year":"2012","unstructured":"Zhou L, Hanemann CO (2012) Merlin, a multi-suppressor from cell membrane to the nucleus. FEBS Lett 586:1403\u20131408","journal-title":"FEBS Lett"},{"key":"1342_CR29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"1342_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0248-4900(01)01125-X","volume":"93","author":"C Peyssonnaux","year":"2001","unstructured":"Peyssonnaux C, Eychene A (2001) The Raf\/MEK\/ERK pathway: new concepts of activation. Biol Cell 93:53\u201362","journal-title":"Biol Cell"},{"key":"1342_CR31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH et al (2007) Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773:1263\u20131284","journal-title":"Biochim Biophys Acta"},{"key":"1342_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","volume":"6","author":"MJ Garnett","year":"2004","unstructured":"Garnett MJ, Marais R (2004) Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6:313\u2013319","journal-title":"Cancer Cell"},{"key":"1342_CR33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2009.01.022","volume":"283","author":"C Montagut","year":"2009","unstructured":"Montagut C, Settleman J (2009) Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett 283:125\u2013134","journal-title":"Cancer Lett"},{"key":"1342_CR34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s002340050475","volume":"39","author":"B Fiirgaard","year":"1997","unstructured":"Fiirgaard B, Pedersen CB, Lundorf E (1997) The size of acoustic neuromas: CT and MRI. Neuroradiology 39:599\u2013601","journal-title":"Neuroradiology"},{"key":"1342_CR35","doi-asserted-by":"crossref","first-page":"e17791","DOI":"10.1371\/journal.pone.0017791","volume":"6","author":"R Eijk van","year":"2011","unstructured":"van Eijk R, Licht J, Schrumpf M et al (2011) Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One 6:e17791","journal-title":"PLoS One"},{"key":"1342_CR36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijc.20325","volume":"111","author":"G Saldanha","year":"2004","unstructured":"Saldanha G, Purnell D, Fletcher A et al (2004) High BRAF mutation frequency does not characterize all melanocytic tumor types. Int J Cancer 111:705\u2013710","journal-title":"Int J Cancer"},{"issue":"Suppl 2","key":"1342_CR37","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/modpathol.3801018","volume":"21","author":"M Ladanyi","year":"2008","unstructured":"Ladanyi M, Pao W (2008) Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol 21(Suppl 2):S16\u2013S22","journal-title":"Mod Pathol"},{"key":"1342_CR38","doi-asserted-by":"crossref","first-page":"150960","DOI":"10.1155\/2010\/150960","volume":"2010","author":"S Jancik","year":"2010","unstructured":"Jancik S, Drabek J, Radzioch D et al (2010) Clinical relevance of KRAS in human cancers. J Biomed Biotechnol 2010:150960","journal-title":"J Biomed Biotechnol"},{"key":"1342_CR39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cc.8.9.8255","volume":"8","author":"G Ligresti","year":"2009","unstructured":"Ligresti G, Militello L, Steelman LS et al (2009) PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches. Cell Cycle 8:1352\u20131358","journal-title":"Cell Cycle"},{"key":"1342_CR40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.lungcan.2005.08.009","volume":"50","author":"K Endo","year":"2005","unstructured":"Endo K, Konishi A, Sasaki H et al (2005) Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50:375\u2013384","journal-title":"Lung Cancer"},{"key":"1342_CR41","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/JTO.0b013e31815ba1fa","volume":"2","author":"L Boldrini","year":"2007","unstructured":"Boldrini L, Gisfredi S, Ursino S et al (2007) Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis. J Thorac Oncol 2:1086\u20131090","journal-title":"J Thorac Oncol"},{"key":"1342_CR42","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2217\/pgs.10.86","volume":"11","author":"P Carotenuto","year":"2010","unstructured":"Carotenuto P, Roma C, Rachiglio AM et al (2010) Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR\/sequencing and real-time PCR approach. Pharmacogenomics 11:1169\u20131179","journal-title":"Pharmacogenomics"},{"key":"1342_CR43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000333453","volume":"55","author":"GD Smith","year":"2011","unstructured":"Smith GD, Zhou L, Rowe LR et al (2011) Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens. Acta Cytol 55:576\u2013583","journal-title":"Acta Cytol"},{"issue":"1\u20132","key":"1342_CR44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11010-012-1282-2","volume":"366","author":"W Jiang","year":"2012","unstructured":"Jiang W, Wang W, Fu F et al (2012) A more sensitive platform for the detection of low-abundance BRAF(V600E) mutations. Mol Cell Biochem 366(1\u20132):49\u201358","journal-title":"Mol Cell Biochem"},{"key":"1342_CR45","doi-asserted-by":"crossref","first-page":"e29336","DOI":"10.1371\/journal.pone.0029336","volume":"7","author":"M Yancovitz","year":"2012","unstructured":"Yancovitz M, Litterman A, Yoon J et al (2012) Intra- and inter-tumor heterogeneity of BRAF(V600E) mutations in primary and metastatic melanoma. PLoS One 7:e29336","journal-title":"PLoS One"},{"key":"1342_CR46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jcp.2004.022509","volume":"58","author":"CW Wong","year":"2005","unstructured":"Wong CW, Fan YS, Chan TL et al (2005) BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol 58:640\u2013644","journal-title":"J Clin Pathol"},{"key":"1342_CR47","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.bjc.6602598","volume":"92","author":"W Zuidervaart","year":"2032","unstructured":"Zuidervaart W, Van NF, Stark M et al (2032) Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer 92:2032\u20132038","journal-title":"Br J Cancer"},{"key":"1342_CR48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00005537-199604000-00012","volume":"106","author":"EM Sturgis","year":"1996","unstructured":"Sturgis EM, Woll SS, Aydin F et al (1996) Epidermal growth factor receptor expression by acoustic neuromas. Laryngoscope 106:457\u2013462","journal-title":"Laryngoscope"},{"key":"1342_CR49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.anndiagpath.2006.09.007","volume":"11","author":"RA Prayson","year":"2007","unstructured":"Prayson RA, Yoder BJ, Barnett GH (2007) Epidermal growth factor receptor is not amplified in schwannomas. Ann Diagn Pathol 11:326\u2013329","journal-title":"Ann Diagn Pathol"},{"key":"1342_CR50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto M, Cole BK, Lallemand D et al (2007) Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin. J Cell Biol 177:893\u2013903","journal-title":"J Cell Biol"},{"key":"1342_CR51","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/gte.2004.8.368","volume":"8","author":"AJ Wallace","year":"2004","unstructured":"Wallace AJ, Watson CJ, Oward E et al (2004) Mutation scanning of the NF2 gene: an improved service based on meta-PCR\/sequencing, dosage analysis, and loss of heterozygosity analysis. Genet Test 8:368\u2013380","journal-title":"Genet Test"},{"key":"1342_CR52","first-page":"5601","volume":"9","author":"P Gonzalez-Gomez","year":"2003","unstructured":"Gonzalez-Gomez P, Bello MJ, Alonso ME et al (2003) CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas. Clin Cancer Res 9:5601\u20135606","journal-title":"Clin Cancer Res"},{"key":"1342_CR53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12094-011-0658-1","volume":"13","author":"L Sastre","year":"2011","unstructured":"Sastre L (2011) New DNA sequencing technologies open a promising era for cancer research and treatment. Clin Transl Oncol 13:301\u2013306","journal-title":"Clin Transl Oncol"},{"key":"1342_CR54","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmedgenet-2011-100242","volume":"48","author":"CS Ku","year":"2011","unstructured":"Ku CS, Naidoo N, Wu M et al (2011) Studying the epigenome using next generation sequencing. J Med Genet 48:721\u2013730","journal-title":"J Med Genet"},{"issue":"6","key":"1342_CR55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00428-012-1236-9","volume":"460","author":"M Vries de","year":"2012","unstructured":"de Vries M, Hogendoorn PC, Briaire-de Bruijn I et al (2012) Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas. Virchows Arch 460(6):629\u2013636","journal-title":"Virchows Arch"},{"key":"1342_CR56","first-page":"162","volume":"223","author":"M Allen","year":"2011","unstructured":"Allen M, Louise JJ (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223:162\u2013176","journal-title":"J Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1342-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-012-1342-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-012-1342-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T16:12:54Z","timestamp":1562429574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-012-1342-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,8]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s00428-012-1342-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,8]]}}}